S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
Log in

OTCMKTS:FSDDF - FSD Pharma Stock Price, Forecast & News

$5.80
+0.33 (+6.03 %)
(As of 02/18/2020 04:00 PM ET)
Today's Range
$5.60
Now: $5.80
$5.84
50-Day Range
$5.42
MA: $6.30
$10.86
52-Week Range
$3.43
Now: $5.80
$68.66
Volume1,641 shs
Average Volume6,994 shs
Market Capitalization$43.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of the indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. It has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products. FSD Pharma Inc. is headquartered in Cobourg, Canada.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:FSDDF
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$70,000.00

Profitability

Miscellaneous

EmployeesN/A
Market Cap$43.96 million
Next Earnings Date3/6/2020 (Estimated)
OptionableNot Optionable

Receive FSDDF News and Ratings via Email

Sign-up to receive the latest news and ratings for FSDDF and its competitors with MarketBeat's FREE daily newsletter.


FSD Pharma (OTCMKTS:FSDDF) Frequently Asked Questions

What is FSD Pharma's stock symbol?

FSD Pharma trades on the OTCMKTS under the ticker symbol "FSDDF."

How were FSD Pharma's earnings last quarter?

FSD Pharma Inc (OTCMKTS:FSDDF) released its earnings results on Friday, November, 29th. The company reported ($1.29) earnings per share (EPS) for the quarter. The firm earned $0.01 million during the quarter. View FSD Pharma's Earnings History.

When is FSD Pharma's next earnings date?

FSD Pharma is scheduled to release their next quarterly earnings announcement on Friday, March 6th 2020. View Earnings Estimates for FSD Pharma.

Has FSD Pharma been receiving favorable news coverage?

Headlines about FSDDF stock have been trending somewhat negative this week, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. FSD Pharma earned a news impact score of -1.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for FSD Pharma.

Who are some of FSD Pharma's key competitors?

What other stocks do shareholders of FSD Pharma own?

Who are FSD Pharma's key executives?

FSD Pharma's management team includes the folowing people:
  • Mr. Anthony John Durkacz, Founder & Co-Chairman (Age 43)
  • Dr. Raza Bokhari M.B.A., MBA, Exec. Co-Chairman & Interim CEO (Age 51)
  • Mr. Zeeshan Saeed, Founder, Pres & Director
  • Mr. Donal Carroll, Interim CFO
  • Dr. Sara May, Pres of FV Pharma

How do I buy shares of FSD Pharma?

Shares of FSDDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is FSD Pharma's stock price today?

One share of FSDDF stock can currently be purchased for approximately $5.80.

How big of a company is FSD Pharma?

FSD Pharma has a market capitalization of $43.96 million and generates $70,000.00 in revenue each year. View Additional Information About FSD Pharma.


MarketBeat Community Rating for FSD Pharma (OTCMKTS FSDDF)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  52
MarketBeat's community ratings are surveys of what our community members think about FSD Pharma and other stocks. Vote "Outperform" if you believe FSDDF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FSDDF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Inverted Yield Curve

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel